Mirae Asset Global Investments’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.04K | Buy |
570
+81
| +17% | +$716 | ﹤0.01% | 1540 |
|
|
2025
Q1 | $5.29K | Buy |
489
+24
| +5% | +$260 | ﹤0.01% | 1513 |
|
|
2024
Q4 | $6.05K | Buy |
465
+2
| +0.4% | +$26 | ﹤0.01% | 1547 |
|
|
2024
Q3 | $14K | Buy |
463
+82
| +22% | +$2.48K | ﹤0.01% | 1477 |
|
|
2024
Q2 | $10.5K | Buy |
+381
| New | +$10.5K | ﹤0.01% | 1460 |
|
|
2024
Q1 | – | Sell |
-11,275
| Closed | -$437K | – | 2570 |
|
|
2023
Q4 | $437K | Buy |
11,275
+10,297
| +1,053% | +$400K | ﹤0.01% | 2028 |
|
|
2023
Q3 | $28.8K | Buy |
978
+139
| +17% | +$4.09K | ﹤0.01% | 2561 |
|
|
2023
Q2 | $52.8K | Sell |
839
-428
| -34% | -$26.9K | ﹤0.01% | 2590 |
|
|
2023
Q1 | $59.8K | Sell |
1,267
-3,311
| -72% | -$156K | ﹤0.01% | 2501 |
|
|
2022
Q4 | $318K | Buy |
4,578
+6
| +0.1% | +$416 | ﹤0.01% | 2128 |
|
|
2022
Q3 | $670K | Buy |
4,572
+2,151
| +89% | +$315K | ﹤0.01% | 1712 |
|
|
2022
Q2 | $316K | Buy |
+2,421
| New | +$316K | ﹤0.01% | 1961 |
|